The NAD

ART Antioxidant Nicotinamide riboside Postovulatory oocyte aging

Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 15 05 2024
accepted: 13 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: aheadofprint

Résumé

Postovulatory aging (POA) of oocytes is clinically significant as it mirrors the degeneration observed in maternally aged oocytes, leading to substantial impairments in oocyte quality and the success rates of artificial reproductive technology (ART). The molecular alterations associated with POA, such as the degeneration of the first polar body, an increase in perivitelline space, reactive oxygen species (ROS) accumulation, energy depletion, and chromosomal and DNA damage, underscore the urgency of finding interventions to mitigate these effects. This study aims to identify whether nicotinamide riboside (NR) can prevent POA during the process of in vitro culture and raise the success rates of ART. Taking advantage of an in vitro postovulatory oocyte aging model, we examined the morphological integrity and NAD With 200 μM NR supplementation during in vitro culture for 24 h, the oocytes from POA demonstrated reduced signs of aging-related decline in oocyte quality, including reduced ROS accumulation, improved mitochondrial function, and corrected mis-localization of cortical granules. This improvement in oocyte quality is likely due to the inhibition of oxidative stress via the NAD Current research provides evidence that NR is an efficient and safe natural component that prevents the process of POA and is thus a potential ideal antiaging drug for raising the success rates of ART in clinical practice.

Identifiants

pubmed: 39460833
doi: 10.1007/s10815-024-03263-x
pii: 10.1007/s10815-024-03263-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Fund for Distinguished Young Scholars
ID : 82225019
Organisme : Key Technologies Research and Development Program
ID : 2021YFC2700303
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 82192873
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 81971381
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 82101714
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 81771580

Informations de copyright

© 2024. The Author(s).

Références

Keefe D, Kumar M, Kalmbach K. Oocyte competency is the key to embryo potential. Fertil Steril. 2015;103(2):317–22.
doi: 10.1016/j.fertnstert.2014.12.115 pubmed: 25639967
Sirait B, Wiweko B, Jusuf AA, Iftitah D, Muharam R. Oocyte competence biomarkers associated with oocyte maturation: a review. Front Cell Dev Biol. 2021;9:710292.
doi: 10.3389/fcell.2021.710292 pubmed: 34527670 pmcid: 8435600
Jiang, Y., He, Y., Pan, X., Wang, P., Yuan, X., and Ma, B. (2023). Advances in oocyte maturation in vivo and in vitro in mammals. Int J Mol Sci 24(10).
Chamayou S. Oocyte quality in assisted reproduction techniques. Minerva Endocrinol (Torino). 2022;47(1):89–98.
pubmed: 35420005
Park SU, Walsh L, Berkowitz KM. Mechanisms of ovarian aging. Reproduction. 2021;162(2):R19-r33.
doi: 10.1530/REP-21-0022 pubmed: 33999842 pmcid: 9354567
Fissore RA, Kurokawa M, Knott J, Zhang M, Smyth J. Mechanisms underlying oocyte activation and postovulatory ageing. Reproduction. 2002;124(6):745–54.
doi: 10.1530/rep.0.1240745 pubmed: 12530912
Di Nisio V, Antonouli S, Damdimopoulou P, Salumets A, Cecconi S. In vivo and in vitro postovulatory aging: when time works against oocyte quality? J Assist Reprod Genet. 2022;39(4):905–18.
doi: 10.1007/s10815-022-02418-y pubmed: 35312936 pmcid: 9050976
Premkumar KV, Chaube SK. An insufficient increase of cytosolic free calcium level results postovulatory aging-induced abortive spontaneous egg activation in rat. J Assist Reprod Genet. 2013;30(1):117–23.
doi: 10.1007/s10815-012-9908-6 pubmed: 23239129
Takahashi T, Igarashi H, Amita M, Hara S, Matsuo K, Kurachi H. Molecular mechanism of poor embryo development in postovulatory aged oocytes: mini review. J Obstet Gynaecol Res. 2013;39(10):1431–9.
doi: 10.1111/jog.12111 pubmed: 23876057
Martin JH, Nixon B, Cafe SL, Aitken RJ, Bromfield EG, Lord T. Oxidative stress and reproductive function: oxidative stress and in vitro ageing of the post-ovulatory oocyte: an update on recent advances in the field. Reproduction. 2022;164(6):F109-f124.
doi: 10.1530/REP-22-0206 pubmed: 36190194
Lord T, Nixon B, Jones KT, Aitken RJ. Melatonin prevents postovulatory oocyte aging in the mouse and extends the window for optimal fertilization in vitro. Biol Reprod. 2013;88(3):67.
doi: 10.1095/biolreprod.112.106450 pubmed: 23365415
Lord T, Aitken RJ. Oxidative stress and ageing of the post-ovulatory oocyte. Reproduction. 2013;146(6):R217-227.
doi: 10.1530/REP-13-0111 pubmed: 23950493
Zhou J, Xue Z, He HN, Liu X, Yin SY, Wu DY, et al. Resveratrol delays postovulatory aging of mouse oocytes through activating mitophagy. Aging (Albany NY). 2019;11(23):11504–19.
doi: 10.18632/aging.102551 pubmed: 31834867
Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–41.
doi: 10.1038/s41580-020-00313-x pubmed: 33353981
Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208–13.
doi: 10.1126/science.aac4854 pubmed: 26785480
Katsyuba E, Romani M, Hofer D, Auwerx J. NAD(+) homeostasis in health and disease. Nat Metab. 2020;2(1):9–31.
doi: 10.1038/s42255-019-0161-5 pubmed: 32694684
Liang J, Huang F, Song Z, Tang R, Zhang P, Chen R. Impact of NAD+ metabolism on ovarian aging. Immun Ageing. 2023;20(1):70.
doi: 10.1186/s12979-023-00398-w pubmed: 38041117 pmcid: 10693113
Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell. 2004;117(4):495–502.
doi: 10.1016/S0092-8674(04)00416-7 pubmed: 15137942
Sharma, A., Chabloz, S., Lapides, R.A., Roider, E., and Ewald, C.Y. (2023). Potential synergistic supplementation of NAD+ promoting compounds as a strategy for increasing healthspan. Nutrients 15(2).
Alegre GFS, Pastore GM. NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR): potential dietary contribution to health. Curr Nutr Rep. 2023;12(3):445–64.
doi: 10.1007/s13668-023-00475-y pubmed: 37273100
Hu L, Guo Y, Song L, Wen H, Sun N, Wang Y, et al. Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1α-PPARα pathway. Free Radic Biol Med. 2022;183:75–88.
doi: 10.1016/j.freeradbiomed.2022.03.012 pubmed: 35318101
Sambeat A, Ratajczak J, Joffraud M, Sanchez-Garcia JL, Giner MP, Valsesia A, et al. Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage. Nat Commun. 2019;10(1):4291.
doi: 10.1038/s41467-019-12262-x pubmed: 31541116 pmcid: 6754455
Bertoldo MJ, Listijono DR, Ho WJ, Riepsamen AH, Goss DM, Richani D, et al. NAD(+) repletion rescues female fertility during reproductive aging. Cell Rep. 2020;30(6):1670-1681.e1677.
doi: 10.1016/j.celrep.2020.01.058 pubmed: 32049001 pmcid: 7063679
Miao Y, Cui Z, Gao Q, Rui R, Xiong B. Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep. 2020;32(5):107987.
doi: 10.1016/j.celrep.2020.107987 pubmed: 32755581
Ear PH, Chadda A, Gumusoglu SB, Schmidt MS, Vogeler S, Malicoat J, et al. Maternal nicotinamide riboside enhances postpartum weight loss, juvenile offspring development, and neurogenesis of adult offspring. Cell Rep. 2019;26(4):969-983.e964.
doi: 10.1016/j.celrep.2019.01.007 pubmed: 30673618
Li H, Wang H, Xu J, Zeng X, Sun Y, Yang Q. Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline. Reproduction. 2023;165(1):103–11.
doi: 10.1530/REP-22-0095 pubmed: 36269127
Yang Q, Chen W, Cong L, Wang M, Li H, Wang H, et al. NADase CD38 is a key determinant of ovarian aging. Nat Aging. 2024;4(1):110–28.
doi: 10.1038/s43587-023-00532-9 pubmed: 38129670
Yin, Z., Sun, J.T., Cui, H.D., Jiang, C.Q., Zhang, Y.T., Lee, S., et al. (2021). Tannin supplementation improves oocyte cytoplasmic maturation and subsequent embryo development in pigs. Antioxidants (Basel) 10(10).
Hu L, Lin L, Huang G, Xie Y, Peng Z, Liu F, et al. Metabolomic profiles in serum and urine uncover novel biomarkers in children with nephrotic syndrome. Eur J Clin Invest. 2023;53(7):e13978.
doi: 10.1111/eci.13978 pubmed: 36856027
Wang Y, Li L, Fan LH, Jing Y, Li J, Ouyang YC, et al. N-acetyl-L-cysteine (NAC) delays post-ovulatory oocyte aging in mouse. Aging (Albany NY). 2019;11(7):2020–30.
doi: 10.18632/aging.101898 pubmed: 30978175
Dai X, Lu Y, Zhang M, Miao Y, Zhou C, Cui Z, et al. Melatonin improves the fertilization ability of post-ovulatory aged mouse oocytes by stabilizing ovastacin and Juno to promote sperm binding and fusion. Hum Reprod. 2017;32(3):598–606.
pubmed: 28137755
Zhang M, ShiYang X, Zhang Y, Miao Y, Chen Y, Cui Z, et al. Coenzyme Q10 ameliorates the quality of postovulatory aged oocytes by suppressing DNA damage and apoptosis. Free Radic Biol Med. 2019;143:84–94.
doi: 10.1016/j.freeradbiomed.2019.08.002 pubmed: 31398498
Xu W, Li L, Sun J, Zhu S, Yan Z, Gao L, et al. Putrescine delays postovulatory aging of mouse oocytes by upregulating PDK4 expression and improving mitochondrial activity. Aging (Albany NY). 2018;10(12):4093–106.
doi: 10.18632/aging.101699 pubmed: 30554191 pmcid: 6326651
Luo D, Zhang JB, Li SP, Liu W, Yao XR, Guo H, et al. Imperatorin ameliorates the aging-associated porcine oocyte meiotic spindle defects by reducing oxidative stress and protecting mitochondrial function. Front Cell Dev Biol. 2020;8:592433.
doi: 10.3389/fcell.2020.592433 pubmed: 33409275 pmcid: 7779485
Mehmel, M., Jovanović, N., and Spitz, U. (2020). Nicotinamide riboside-the current state of research and therapeutic uses. Nutrients 12(6).
Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529–47.
doi: 10.1016/j.cmet.2018.02.011 pubmed: 29514064 pmcid: 6342515
Zhang H, Li C, Liu Q, Li J, Wu H, Xu R, et al. C-type natriuretic peptide improves maternally aged oocytes quality by inhibiting excessive PINK1/Parkin-mediated mitophagy. Elife. 2023;12:88523.
doi: 10.7554/eLife.88523.3
Rojas J, Hinostroza F, Vergara S, Pinto-Borguero I, Aguilera F, Fuentes R, et al. Knockin’ on egg’s door: maternal control of egg activation that influences cortical granule exocytosis in animal species. Front Cell Dev Biol. 2021;9:704867.
doi: 10.3389/fcell.2021.704867 pubmed: 34540828 pmcid: 8446563
Miao YL, Kikuchi K, Sun QY, Schatten H. Oocyte aging: cellular and molecular changes, developmental potential and reversal possibility. Hum Reprod Update. 2009;15(5):573–85.
doi: 10.1093/humupd/dmp014 pubmed: 19429634
Handy DE, Loscalzo J. The role of glutathione peroxidase-1 in health and disease. Free Radic Biol Med. 2022;188:146–61.
doi: 10.1016/j.freeradbiomed.2022.06.004 pubmed: 35691509 pmcid: 9586416
Wang L, Chen Y, Wei J, Guo F, Li L, Han Z, et al. Administration of nicotinamide mononucleotide improves oocyte quality of obese mice. Cell Prolif. 2022;55(11):e13303.
doi: 10.1111/cpr.13303 pubmed: 35811338 pmcid: 9628229

Auteurs

Tianjie Li (T)

Department of Obstetrics and Gynecology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, 100050, China.
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China.
State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, 100191, China.

Yibo Wang (Y)

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China.
State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, 100191, China.
Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing, 100191, China.
Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.

Yang Yu (Y)

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China.
State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, 100191, China.
Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing, 100191, China.

Wendi Pei (W)

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China.
State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, 100191, China.
Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing, 100191, China.

Lin Fu (L)

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China.
State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, 100191, China.
Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing, 100191, China.

Dan Jin (D)

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Strategic Support Force Medical Center, Beijing, 100101, China. demitj1980@126.com.

Jie Qiao (J)

Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, 100191, China. jie.qiao@263.net.
State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, 100191, China. jie.qiao@263.net.

Classifications MeSH